InvestSMART

INOVIQ Ltd (ASX: IIQ) - Announcements

Current share price for IIQ : $0.195 0.005 (2.50%)+

ASX company news and announcements for INOVIQ Ltd (IIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All INOVIQ Ltd (IIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than INOVIQ Ltd (IIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for INOVIQ Ltd (IIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$27 2025 Annual Report 18 Sep 2025 11:08AM $0.385 $0.195 fallen by 49.35%
$27 Investor Webinar Presentation 27 Aug 2025 11:23AM $0.400 $0.195 fallen by 51.25%
$27 Appendix 4G and Corporate Governance Statement 22 Aug 2025 10:48AM $0.410 $0.195 fallen by 52.44%
$27 Appendix 4E and Preliminary Financial Report 22 Aug 2025 10:45AM $0.410 $0.195 fallen by 52.44%
$27 Quarterly Business Update and Appendix 4C - June 2025 31 Jul 2025 8:42AM $0.365 $0.195 fallen by 46.58%
$27 INOVIQ Investor Events 28 Jul 2025 8:57AM $0.370 $0.195 fallen by 47.30%
$27 INOVIQ Investor Webinar Presentation Slides 14 Jul 2025 3:18PM $0.390 $0.195 fallen by 50%
$27 INOVIQ Investor Briefing 9 Jul 2025 3:28PM $0.355 $0.195 fallen by 45.07%
$27 Response to ASX Query 23 Jun 2025 4:21PM $0.380 $0.195 fallen by 48.68%
$27 New treatment kills 88% of Breast and Lung Cancer cells 18 Jun 2025 8:47AM $0.388 $0.195 fallen by 49.68%
$27 Reinstatement to Official Quotation 2 Jun 2025 10:31AM $0.440 $0.195 fallen by 55.68%
$27 Early Ovarian Cancer Screening Breakthrough 2 Jun 2025 10:30AM $0.440 $0.195 fallen by 55.68%
$27 Suspension from Quotation 28 May 2025 9:42AM $0.440 $0.195 fallen by 55.68%
$27 Response to ASX Price Query 28 May 2025 9:38AM $0.440 $0.195 fallen by 55.68%
$27 Trading Halt 26 May 2025 10:06AM $0.440 $0.195 fallen by 55.68%
$27 Pause in Trade 26 May 2025 9:53AM $0.440 $0.195 fallen by 55.68%
$27 Notification of cessation of securities - IIQ 1 May 2025 2:19PM $0.355 $0.195 fallen by 45.07%
$27 Quarterly Business Update and Appendix 4C - March 2025 30 Apr 2025 9:18AM $0.370 $0.195 fallen by 47.30%
$27 Notification regarding unquoted securities - IIQ 9 Apr 2025 4:08PM $0.380 $0.195 fallen by 48.68%
$27 Application for quotation of securities - IIQ 7 Apr 2025 12:23PM $0.390 $0.195 fallen by 50%
$27 Proposed issue of securities - IIQ 4 Apr 2025 11:15AM $0.415 $0.195 fallen by 53.01%
$27 CAR-exosome therapy webinar presentation slides 3 Apr 2025 3:22PM $0.410 $0.195 fallen by 52.44%
$27 Publication of NeuCA15-3 assay data 1 Apr 2025 8:43AM $0.405 $0.195 fallen by 51.85%
$27 IIQ to work with Peter Mac to validate car-exosome therapy 31 Mar 2025 9:27AM $0.405 $0.195 fallen by 51.85%
$27 Ceasing to be a substantial holder 25 Mar 2025 10:47AM $0.400 $0.195 fallen by 51.25%

51 - 75 of 249 results

Page 3 of 10

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.